BERLIN (dpa-AFX) - Siemens AG announced its decision to deconsolidate its remaining approximately 67% stake in Siemens Healthineers. This strategic move, approved today by both the Managing Board ...

© Foto: Malte Ossowski/SVEN SIMON - SVEN SIMONSingapore Airlines rutscht wegen der Air-India-Last im zweiten Quartal tief in die Krise und hofft trotz wachsender Unsicherheiten auf eine Trendwende.Sin ...

Dassault Aviation is delighted to be participating in the Dubai Airshow from November 17 to 21. Since 1973 and ...

Delivery Volume growth of 66% quarter over quarter, a 300% increase from third quarter 2024Entered new multi-year strategic partnership with DoorDash to roll out deliveries across the U.S.Launched Chi ...

24.10. Torchlight Innovations Inc.: Torchlight and Innovation Mining Unite as RZOLV Technologies on the TSXV with Disruptive New Mining Technology 442 Newsfile Vancouver, British Columbia--(Newsfile C ...

HAMBURG/BREMEN (dpa-AFX) - Die französische Reederei CMA CGM will im Hamburger Hafen einsteigen. Geplant ist, dass sie sich mit 20 Prozent am Eurogate-Terminal in Hamburg beteiligt, wie CMA CGM und Eu ...

EQS-News: Reply SpA / Schlagwort(e): Quartalsergebnis REPLY: Der Verwaltungsrat genehmigt den Quartalsfinanzbericht zum 30. September 2025 13.11.2025 / 12:37 CET/CEST Für ...

Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue increased by 85%, to $237 million in the first nine mon ...

Completed strategic pivot from R&D focus to commercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize commercial engagement and investor relationsAdvanced mu ...

Company plans new, confirmatory Phase 3 clinical trial of LYR-210 for treatment of chronic rhinosinusitis (CRS) without nasal polyps, on path to NDA submission - WATERTOWN, Mass., Nov. 12, 2025 (GLOBE ...

Captivision Inc. ("Captivision" or the "Company") (NASDAQ: CAPT), a pioneering manufacturer and global LED solution provider, today announced that it had received ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused ...